Dermatology · Williamsville, NY
NPI
1285733014
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
13
Medicare group memberships
Hospitals
0
Hospital affiliations
8207 Main St, Suite 14
Williamsville, NY, 14221
Phone (716) 204-5350
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,931
95 services
Medicare patients, 2024
49
Average age 72
Drug cost, 2024
$266K
49 prescriptions
Company payments, 2025
$4,139
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Animesh A Sinha was code 99213 (office e&m - established), 24 times for 23 patients. In total Animesh A Sinha billed 95 services in 27 codes, and Medicare paid $5,931.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 24 | 23 | $66.77 | $1,602 |
By year: 2022 $4,452 for 76 services; 2023 $3,830 for 76 services; 2024 $5,931 for 95 services.
Medicare prescription drug claims, 2024
In 2024, the drug Animesh A Sinha prescribed most often to Medicare patients was Mycophenolate Mofetil, with 11 prescriptions and refills. In total Animesh A Sinha wrote 49 Medicare prescriptions that cost $266K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mycophenolate Mofetil Generic | 11 | 11 | Under 11 | $311 |
| Bivigam Immun Glob G(Igg)/Gly/Iga Ov50 | 11 | 11 | Under 11 | $265K |
Brand drugs: 12 claims; generic drugs: 37 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Animesh A Sinha $4,139 ($4,139 in general payments such as food, travel and fees) from 7 companies. The largest payer was Revvity, Inc. with $3,000.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.